You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 3050Biotin 721FITC 702HRP 688PE 621APC 453Cy3 418AP 417PerCP 371BF488 358PE/Cy5 358APC/Cy5.5 357APC/Cy7 357BF405 357BF647 357PE/Cy5.5 357PE/Cy7 357PerCP/Cy5.5 357BF555 356Pacific Blue 356PerCP/Cy7 356BF350 355BF594 355BF680 355BF700 355BF750 355Cy5 355Cy5.5 355RBITC 355Cy7 354IRDye800 261AE 75iFluor647 62RPE 14SureLight 488 6IRDye800CW 2MMAE 1
Biologically Active
Featured Product
1.57-100 ng/mL
0.48 ng/mL
96 T, 48 T1.57-100 ng/mL
0.49 ng/mL
48 T, 96 T0.16-10 ng/mL
0.062 ng/mL
48 T, 96 T0.63-40 ng/mL
0.15 ng/mL
96 T, 48 T15.63-1000 pg/mL
7.1 pg/mL
48 T, 96 T
Biotinylated Mouse TRAIL R2 [orb2994246]Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.4 KDa. Observed: 20-40 KDa, reducing conditions
100 μg, 20 μg- Human PCSK9 [orb2992748]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 71.9 KDa. Observed: (17-21)&(60-70) KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human PCSK9 V2 [orb2992796]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 71.9 KDa. Observed: (15-19)&(60-80) KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human Bcl-xL [orb2993654]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.85 KDa. Observed: 29 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg